ArticleFrontiers in immunology2022

Poly-L-Lysine-Based αGal-Glycoconjugates for Treating Anti-αGal IgE-Mediated Diseases.

Sara Olivera-Ardid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.